The Diagnostic Value of Serum Glypican-3 in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Journal Title: International Journal of Health & Medical Research - Year 2023, Vol 2, Issue 09
Abstract
Background and aim: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. It is curable in the early stages but has a poor prognosis when advanced. Current diagnostic protocols for the early stages of HCC are inefficient. Serum Glypican-3 (GPC-3) is a promising serum tumour marker in diagnosing HCC, and its diagnostic value has been explored in various studies. The outcomes, however, continue to be inconsistent and controversial. This systematic review and meta-analysis aimed to investigate the diagnostic accuracy of serum GPC-3 in hepatocellular carcinoma. This study included recent papers not captured in previous meta-analyses. Method: PUBMED, MEDLINE, Cochrane Library, and CINAHL databases were systematically searched according to preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies guidelines. Studies on the diagnostic accuracy of serum GPC-3 in HCC were selected. The Quality assessment of diagnostic accuracy studies 2 (QUADAS-2) tools were used to assess the quality of selected studies. Sensitivity, specificity, and other diagnostic parameters were pooled using the random effect model. The Summary receiver operating characteristic (sROC) was used to summarise the diagnostic accuracy of Serum GPC-3. Results: Eleven studies were included in this systematic review. The pooled sensitivity, specificity, and 95% confidence intervals (CIs) were 0.60 (0.57-0.62) and 0.67(0.64-0.70), respectively. The pooled positive and negative likelihood ratios and 95% CIs were 2.11 (1.51-2.93) and 0.59 (0.51-0.68), respectively; the pooled diagnostic odds ratio and the 95% CI were 4.07 (2.37-6.98), the area under the sROC curve was 0.7194. Conclusion: This meta-analysis has shown that Serum GPC-3 has an acceptable diagnostic value in diagnosing HCC compared to benign chronic liver diseases. A higher-quality study with a larger sample size is necessary to thoroughly assess the diagnostic utility of serum GPC-3.
Authors and Affiliations
Arinze I. Aninworie, MD, MSc
Keywords
Related Articles
- EP ID EP731145
- DOI 10.58806/ijhmr.2023.v2i9n05
- Views 52
- Downloads 0
Management of Twin Pregnancies and The Risk of Fetal Death
Introduction: Twin pregnancies can present risks to both mother and fetus. One of the biggest concerns in twin pregnancies is premature birth. Objectives: To discuss the management of twin pregnancies in order to avoid...
Relationship between Mother and Child Behavior in Maintaining Dental Health with the Incidence of Caries (Study of Preschool Children at AlMasyithoh Pati Muslimat Kindergarten)
Background: Dental caries is still a priority issue in children's health. The high prevalence of caries in children is partly due to the lack of maternal behavior in maintaining oral health, as well as a child's diet. T...
Levels of Nutritional Adequacy and Bioavailability of Iron with The Incident of Anemia in Pregnant Women in Gorontalo City
The level of adequate nutrition and iron availability in pregnant women can cause anemia, and inadequate food intake during pregnancy can affect Hb levels. The research formulation is about the incidence of anemia in pre...
Identification Of Locally Transmitted COVID-19 Spatial Clusters And Hotspots
Background: The coronavirus disease 2019 (COVID-19) is an emerging and rapidly evolving profound pandemic, which causes severe acute respiratory syndrome and results in significant case fatality around the world. We cond...
Revisiting Scalp Tissue Expander in Indonesia: Restoration of Cicatricial Alopecia
Background: Scalp alopecia from burn injuries significantly impacts physical appearance and psychological well-being, often leading to social phobia. Tissue expanders have been effective in reconstructive surgeries, offe...